RAPT Therapeutics Inc (RAPT)
8.33
+0.20
(+2.52%)
USD |
NASDAQ |
May 03, 16:00
8.33
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Cash from Operations (TTM): -97.05M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -97.05M |
September 30, 2023 | -92.14M |
June 30, 2023 | -87.41M |
March 31, 2023 | -73.80M |
December 31, 2022 | -70.77M |
September 30, 2022 | -68.60M |
June 30, 2022 | -63.97M |
March 31, 2022 | -62.69M |
December 31, 2021 | -61.03M |
September 30, 2021 | -55.71M |
June 30, 2021 | -53.14M |
Date | Value |
---|---|
March 31, 2021 | -45.66M |
December 31, 2020 | -40.49M |
September 30, 2020 | -30.81M |
June 30, 2020 | -33.00M |
March 31, 2020 | -35.58M |
December 31, 2019 | -35.47M |
September 30, 2019 | -39.00M |
June 30, 2019 | -35.72M |
March 31, 2019 | -33.97M |
December 31, 2018 | -32.95M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-97.05M
Minimum
Dec 2023
-30.81M
Maximum
Sep 2020
-56.95M
Average
-55.71M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Emergent BioSolutions Inc | -206.30M |
Avinger Inc | -14.43M |
Tonix Pharmaceuticals Holding Corp | -102.00M |
Skye Bioscience Inc | -13.95M |
Axsome Therapeutics Inc | -145.08M |